Related Experiment Video
Updated: Mar 28, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015
Rebecca J Brown1, Louissa Macfarlane-Smith, Sarah Phillips
1Bacteriology Reference Department, Public Health England (PHE), London, United Kingdom.
Abstract:
Mycoplasma pneumoniae infection can cause pneumonia, particularly in children. Global increase in macrolide-resistant M. pneumoniae is of concern due to limited therapeutic options. We describe the detection of macrolide resistance-conferring mutations in 9.3% of 43 clinical specimens where M. pneumoniae was detected in England and Wales from September 2014‒September 2015. This study aims to impact by highlighting the presence of macrolide resistance in M. pneumoniae positive patients, promoting increased clinical vigilance.
Insights
Macrolide resistance is emerging in Mycoplasma pneumoniae, a common cause of childhood pneumonia. This study found resistance mutations in nearly 10% of cases in England and Wales, necessitating increased clinical awareness.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Mycoplasma pneumoniae is a significant cause of community-acquired pneumonia, especially in pediatric populations.
- The rise in macrolide-resistant M. pneumoniae strains globally poses a therapeutic challenge due to limited alternative treatments.
Purpose of the Study:
- To investigate the prevalence of macrolide resistance-conferring mutations in M. pneumoniae within clinical specimens from England and Wales.
- To inform healthcare professionals about the presence of macrolide resistance in M. pneumoniae infections.
Main Methods:
- Analysis of 43 clinical specimens positive for M. pneumoniae.
- Detection of specific mutations associated with macrolide resistance.
Main Results:
- Macrolide resistance-conferring mutations were identified in 9.3% of the analyzed M. pneumoniae clinical specimens.
- The study period was from September 2014 to September 2015.
Conclusions:
- The findings highlight the circulation of macrolide-resistant M. pneumoniae in England and Wales.
- Increased clinical vigilance is recommended for patients with M. pneumoniae infections to ensure appropriate treatment strategies.
Related Concept Videos
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Pneumonia III: Complications and Assessment

